In July, Dr. David F. Penson, past chair of the AUA Public Policy Council, met with the Medicare Payment Advisory Commission (MedPAC) to discuss prostate-specific antigen (PSA) testing, shared decision-making and AUA guidelines. We recently sat down with Dr. Penson to discuss the meeting and...
Late last year, the AUA alerted the urology community to multiple activities at the federal level that threatened a man’s right to prostate cancer screening: a quality measure recommending against PSA screening and a draft research plan from the U.S. Preventive Services Task Force (USPSTF)...
As previously reported , the AUA alerted its membership to the development of a national quality measure, proposed by the Centers for Medicare & Medicaid Services (CMS), to penalize physicians for ordering a PSA test for any man over the age of 18. Thanks to AUA members and partner...
In June 2015, the AUA released its second list of “Five Things that Physicians and Patients Should Question” as part of the Choosing Wisely campaign, an initiative of the ABIM Foundation. The AUA recently sat down with Dr. Ian M. Thompson Jr. to discuss the fourth item on the AUA’s 2015...